Zelquistinel Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: GATE-251

Filter by location:

Birmingham, Alabama1 trial

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder

University of Alabama at Birmingham

Phase 2

Phoenix, Arizona1 trial

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia

NoesisPharma, LLC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.